10-K Decoder · All companies

Aurinia Pharmaceuticals Inc.

AUPH · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$283M$235M+20.4%
Operating income$105M−$4.69M
Net income$287M$5.75M+4,895%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 30, 2026

$Q3 2026Year earlierChange
Revenue$83.7M$73.5M+13.9%
Operating income$35.4M$29.7M+19.2%
Net income$31.7M$31.6M+0.3%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Aurinia's revenue in FY2025?
$283M in FY2025 (Fiscal year ended Dec 31, 2025), +20.4% vs $235M a year earlier, per its 10-K filed Feb 2026.
Was Aurinia profitable in FY2025?
Yes: net income was $287M and operating income $105M in FY2025.
What was Aurinia's revenue in Q3 2026?
$83.7M (+13.9% vs a year earlier), per its Form 10-Q filed Oct 30, 2026.